GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $402,000 | -29.7% | 9,226 | -29.7% | 0.00% | -20.0% |
| Q1 2022 | $572,000 | -17.6% | 13,121 | -16.6% | 0.01% | -16.7% |
| Q4 2021 | $694,000 | -31.8% | 15,738 | -40.9% | 0.01% | -33.3% |
| Q3 2021 | $1,018,000 | +17.1% | 26,635 | +22.1% | 0.01% | +28.6% |
| Q2 2021 | $869,000 | +11.0% | 21,812 | -0.6% | 0.01% | 0.0% |
| Q1 2021 | $783,000 | -14.7% | 21,936 | -12.0% | 0.01% | -22.2% |
| Q4 2020 | $918,000 | -32.9% | 24,935 | -31.4% | 0.01% | -40.0% |
| Q3 2020 | $1,368,000 | -15.6% | 36,337 | -8.5% | 0.02% | -16.7% |
| Q2 2020 | $1,620,000 | +21.8% | 39,720 | +13.2% | 0.02% | +12.5% |
| Q1 2020 | $1,330,000 | -19.2% | 35,093 | +0.2% | 0.02% | +23.1% |
| Q4 2019 | $1,647,000 | -9.1% | 35,040 | -17.4% | 0.01% | -13.3% |
| Q3 2019 | $1,811,000 | +11.1% | 42,440 | +4.2% | 0.02% | +25.0% |
| Q2 2019 | $1,630,000 | -13.7% | 40,740 | -9.8% | 0.01% | -14.3% |
| Q1 2019 | $1,888,000 | – | 45,180 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |